chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Fever; vomit next day; diarrhea 3 days; extreme pain shoulder; extreme pain arm 3 days; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 76-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Right on 19Feb2021 at 13:45 pm (at the age of 76-years-old) (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing other (was Hospitalized with covid from 31Oct2021-11Apr2020) and ongoing blood pressure and thyroid disorder. Patient had no known allergies. Concomitant medications included unspecified medications for blood pressure and thyroid. Facility type vaccine was reported as doctor's office/urgent care. It was reported that patient received the first dose of vaccine and on 19Feb2021 at 16:00 pm experienced fever lasted 4 days, vomit next day, diarrhea 3 days and extreme pain shoulder, arm 3 days. Patient had not received any treatment to treat the event. Post vaccination patient had not tested for covid. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Headache
Clinical narrative: Fever up to 102. Chills; Chills; Muscle aches; Joint pain; Mssive headache; Nausea; Weakness; Injection site soreness; This is a spontaneous report from a contactable consumer (Patient). A 42-years-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 19Feb2021 12:30 (at the age of 42-years-old) as dose 2, single for COVID-19 immunization. Medical history included allergies to sulpha drug from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included sertraline, diltiazem taken for an unspecified indication, start and stop date were not reported and colecalciferol (D3) for supplementation therapy, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: EL9264) in left arm on Jan2021 at 10:30 (at the age of 42 years old) for covid-19 immunisation. No other medical history was reported. On 19Feb2021 at 23:00 the patient experienced fever up to 102. Chills, muscle aches joint pain, massive headache, nausea, weakness, and injection site soreness. On 19Feb2021 the patient underwent lab tests and procedures which included body temperature as 102. The patient did not receive any treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Fever up to 102. Chills; Chills; Muscle aches; Joint pain; Mssive headache; Nausea; Weakness; Injection site soreness; This is a spontaneous report from a contactable consumer (Patient). A 42-years-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 19Feb2021 12:30 (at the age of 42-years-old) as dose 2, single for COVID-19 immunization. Medical history included allergies to sulpha drug from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included sertraline, diltiazem taken for an unspecified indication, start and stop date were not reported and colecalciferol (D3) for supplementation therapy, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: EL9264) in left arm on Jan2021 at 10:30 (at the age of 42 years old) for covid-19 immunisation. No other medical history was reported. On 19Feb2021 at 23:00 the patient experienced fever up to 102. Chills, muscle aches joint pain, massive headache, nausea, weakness, and injection site soreness. On 19Feb2021 the patient underwent lab tests and procedures which included body temperature as 102. The patient did not receive any treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: After the injection my lips started to tingle and not long after my lips and tongue felt numb; After the injection my lips started to tingle and not long after my lips and tongue felt numb.; This is a spontaneous report from a contactable consumer (patient). A 41-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6202, Expiry date: not reported), via an unspecified route of administration, administered in Arm Left on 27Feb2021 at 16:15 (at the age of 41-year-old) as Dose 1, Single for COVID-19 immunization at hospital. Medical history included asthma from an unknown date and unknown if ongoing. There were no concomitant medications. No allergies known. If other vaccine in four weeks and other medications in two weeks was mentioned as no. If COVID prior vaccination and if COVID tested post vaccination was mentioned as no. The reporter stated on 27Feb2021 at 16:30 approximately 20 minutes after the injection my lips started to tingle and not long after my lips and tongue felt numb. My provider advised over the phone that I take an anti-histamine, which helped.  Adverse event resulted in none of the above. The outcome of events was recovering.  Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Pins and needles / feelings of mild numbness in injection arm and face, starting within minutes of the injection and still continuing as of 28 hours post-injection (at time of this report); Pins and needles / feelings of mild numbness in injection arm and face, starting within minutes of the injection and still continuing as of 28 hours post-injection (at time of this report); Pins and needles / feelings of mild numbness in injection arm and face, starting within minutes of the injection and still continuing as of 28 hours post-injection (at time of this report); This is a spontaneous report from a contactable consumer (Patient). A non-pregnant 35-year-old female patient received BNT162B2 (COMIRANTY; Formulation: Solution for injection; Lot number: Unknown, Expiration date: was not reported, Age at vaccination: 35-year-old) via an unspecified route of administration in the left arm on 26Feb2021 at 16:30 as dose 1, single for COVID-19 immunization. Medical history included rheumatoid arthritis. Concomitant medications included Enbrel [ETANERCEPT], Allegra [FEXOFENADINE HYDROCHLORIDE] taken for unspecified indication and start date not reported. On 26Feb2021 at 16:30, patient experienced pins and needles / feelings of mild numbness in injection arm and face, starting within minutes of the injection and still continuing as of 28 hours post-injection. Facility type vaccine was pharmacy or drug store. No other vaccine taken in four weeks. No covid prior vaccination. Patient was not tested for covid post vaccination. Patient had no known allergies. No treatment for adverse event was taken. The outcome of all events was not recovered.  No follow up attempts are possible; information on Lot/batch number cannot be obtained.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vaccination site pain
Clinical narrative: numbness and pins and needle feeling in left arm and leg; numbness and pins and needle feeling in left arm and leg; Injection site was sore for 1 week; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot Number: EN9501), via an unspecified route of administration, administered in left arm on 11Feb2021 at 15:30 (at the age of 68-year-old) as dose 1, single for COVID-19 immunisation. Medical history included AFib (atrial fibrillation). Concomitant medications included rivaroxaban (XARELTO); digoxin; metoprolol; amiodarone, all drugs received within 2 weeks of vaccination. The patient previously took keflex (cefalexin) and had known allergies keflex. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 20Feb2021, the patient experienced injection site was sore for 1 week. Now the patient had numbness and pins and needle feeling in left arm and leg. No treatment was received for the events. The outcome of the events of numbness and pins and needle feeling in left arm and leg was not recovered and other event of Injection site was sore for 1 week was recovered on 27Feb2021.  No follow up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Hypoaesthesia
Clinical narrative: numbness in left hand which minimized to numbness in pinkie finger of left hand; had a nose bleed; Numbness in pinkie finger is continuing; This is a spontaneous report from a contactable consumer (patient herself).   A 65-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration, administered in left arm on 25Feb2021 06:45 (age at vaccination: 65-years) as dose number unknown, single for Covid-19 immunisation. Patient was not pregnant at the time of vaccination. Facility type vaccine was hospital. Patient was not diagnosed with covid prior to vaccination. She was not tested for covid since vaccination. Patients medical history included hashimotos and known allergies: sulfa from an unspecified date and unknown if ongoing. Past drug event included known allergies due to clindamycin, amoxicillin and sulfa from an unspecified date and unknown if ongoing. Concomitant medications reported were lisinopril and armour thyroid start and stop date unknown, taken for unspecified indication, administered in two weeks of vaccination. Patient was not administered any other vaccines within four weeks. On Friday, 26Feb2021 06:30 AM, patient woke up with numbness in left hand which minimized to numbness in pinkie finger of left hand. On Saturday about 2:30 p.m. she had a nose bleed which was a rare occurrence for her. The numbness in pinkie finger was continuing. No treatment regimen was given as a result of the adverse events. The outcome of the events was not recovered.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia, Swelling
Clinical narrative: fever of 102 (degree) Fahrenheit; severe chills; under her armpit and right around her collar bone was very swollen; Headache; This is a spontaneous report from a contactable consumer (patient). A 70-years-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9266; Expiration Date: May2021, NDC and UPC number were unknown), via an unspecified route of administration on 24Feb2021 as dose 1, single (at the age of 70-years-old) for covid-19 immunisation. Medical history included asthma and rapid heartbeat (both from an unknown date and unknown if ongoing). Concomitant medication(s) included propranolol taken for rapid heartbeat, start and stop date were not reported. On 25Feb2021, patient experienced severe chills, headache, fever of 102 (degree) Fahrenheit and swelling of her collar bone and left under armpit. Patient stated that she still had very swollen right by the collar bone and under her armpit and had slight chills, not anything like before. Patient would like to know if her symptoms were normal. Patient was scheduled to receive the second dose of the vaccine on 17Mar2021. Patient stated that she fears that the second dose side effects may be more severe. Patient would like to know if she should receive the second dose of the vaccine. Therapeutic measures were taken as a result of fever of 102 (degree) Fahrenheit, severe chills, under her armpit and right around her collar bone was very swollen, headache and treatment included Tylenol. The outcome of fever of 102 (degree) Fahrenheit was recovered on Feb2021, swelling of her collar bone and left under armpit and severe chills was not recovered and unknown for headache.  No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Gingival blister, Lethargy, Oral mucosal blistering
Clinical narrative: fever; chills; aches; lethargy; abdominal pain; vomiting; blistered mouth and gums; blistered mouth and gums; This is a spontaneous report from a contactable consumer (patient herself). A 74-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 24Feb2021 11:45 (age at vaccination: 74 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included arthritis, neoplasm malignant, psoriasis, cardiac disorder and ibuprofen hypersensitivity. The patient's concomitant medications were not reported. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL8982) via unknown route in left arm on 03Feb2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation. The patient was administered vaccine in a public health clinic. On 24Feb2021 18:00, the patient experienced fever, chills, aches, lethargy, abdominal pain, vomiting and blistered mouth and gums. The patient did not have any other vaccine in four weeks. The patient did not have covid prior vaccination nor was tested positive since vaccination. The outcome of all the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vomiting
Clinical narrative: fever; chills; aches; lethargy; abdominal pain; vomiting; blistered mouth and gums; blistered mouth and gums; This is a spontaneous report from a contactable consumer (patient herself). A 74-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 24Feb2021 11:45 (age at vaccination: 74 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included arthritis, neoplasm malignant, psoriasis, cardiac disorder and ibuprofen hypersensitivity. The patient's concomitant medications were not reported. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL8982) via unknown route in left arm on 03Feb2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation. The patient was administered vaccine in a public health clinic. On 24Feb2021 18:00, the patient experienced fever, chills, aches, lethargy, abdominal pain, vomiting and blistered mouth and gums. The patient did not have any other vaccine in four weeks. The patient did not have covid prior vaccination nor was tested positive since vaccination. The outcome of all the events was recovering.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: he was prescribed with injections for his arthritis; This is a spontaneous report from a sponsored program. A contactable consumer (patient) reported that a male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) dose 1 via an unspecified route of administration on 13Feb2021 as single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications were unspecified. Patient reported that he had an appointment from a physician, he was prescribed with injections for his arthritis in Feb2021, and he had been injected with the medication and he was asking if it's gonna affect the first dose. The outcome of event was unknown.  Follow-up attempts completed. No further information expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: slightly numbness of tongue (only front part of the tongue).; This is a spontaneous report from a contactable other health care professional (patient). A 52-year-old female (non-pregnant) received BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation; solution for injection; Lot number: EN6202; Batch no: not reported) via Intramuscularly administered in Right arm on 28Feb2021 09:00 AM (at the age of 52-years-old) as dose 1, single for covid-19 immunization at Hospital. Medical history included Grave's disease, hypothyroidism and right shoulder soreness. No known allergies were reported. Concomitant medications included medications within two weeks as Liothyronine sodium; L-thyroxine [LEVOTHYROXINE]; Ubidecarenone (COQ-10); multi-vitamins (gummy chewable); Biotin; Cyanocobalamin (VITAMIN B-12); Hyaluronic acid; Triamcinolone acetonide (NASACORT) all taken for an unspecified indication except Ibuprofen, start and stop date were not reported and Ibuprofen taken for right shoulder soreness (last dose taken on 2/26 evening). No other vaccine received by the patient within four weeks. The patient did not have covid prior vaccination. The patient had not been tested for covid post vaccination. On 28Feb2021 09:30 AM after the vaccination, the patient experienced slightly numbness of tongue (only front part of the tongue). AE dose not resulted in ER or physician office visit. No treatment was received to the event caused. Outcome of the event was not resolved.  No follow-up attempts are possible; Information about batch/ lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Erythema, Fatigue, Headache
Clinical narrative: Pain; Nausea; Headache; Weakness; Injection arm is sore; Last night she had redness on her deltoid area; She was completely exhausted; Three little pink blotchy areas; Fever; she started to feel sick; she was sweating; This is a spontaneous report from a contactable Nurse. This female Nurse reported for herself.  A female patient of unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: EC9267, Expiration date: unknown), via intramuscular, administered in left arm on 19Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history include COVID 19 from unknown onset and concomitant medications were not reported. On 20Feb2021, after the vaccination, the patient experienced fever, and on an unspecified date patient experienced pain, nausea, headaches, and weakness, Injection arm is sore, on 22Feb2021 patient experienced Three little pink blotchy areas. she had redness on her deltoid area, which she knows is normal from the things she read. She has three little pink blotchy areas that came up yesterday and hoping those go away. Her arm is still sore. Asked if that is going to impede her next dose in two weeks. She doesn't want to trigger another reaction. she started to feel sick, temperature went to 100.8, she was sweating. She had headache and nausea off and on. She was completely exhausted. She felt as though she did when she got her issues from the actual COVID virus. The patient lab data includes body temperature with reading of 100.8-degree Fahrenheit. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Illness, Nausea, Pain, Pain in extremity
Clinical narrative: Pain; Nausea; Headache; Weakness; Injection arm is sore; Last night she had redness on her deltoid area; She was completely exhausted; Three little pink blotchy areas; Fever; she started to feel sick; she was sweating; This is a spontaneous report from a contactable Nurse. This female Nurse reported for herself.  A female patient of unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: EC9267, Expiration date: unknown), via intramuscular, administered in left arm on 19Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history include COVID 19 from unknown onset and concomitant medications were not reported. On 20Feb2021, after the vaccination, the patient experienced fever, and on an unspecified date patient experienced pain, nausea, headaches, and weakness, Injection arm is sore, on 22Feb2021 patient experienced Three little pink blotchy areas. she had redness on her deltoid area, which she knows is normal from the things she read. She has three little pink blotchy areas that came up yesterday and hoping those go away. Her arm is still sore. Asked if that is going to impede her next dose in two weeks. She doesn't want to trigger another reaction. she started to feel sick, temperature went to 100.8, she was sweating. She had headache and nausea off and on. She was completely exhausted. She felt as though she did when she got her issues from the actual COVID virus. The patient lab data includes body temperature with reading of 100.8-degree Fahrenheit. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash macular
Clinical narrative: Pain; Nausea; Headache; Weakness; Injection arm is sore; Last night she had redness on her deltoid area; She was completely exhausted; Three little pink blotchy areas; Fever; she started to feel sick; she was sweating; This is a spontaneous report from a contactable Nurse. This female Nurse reported for herself.  A female patient of unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: EC9267, Expiration date: unknown), via intramuscular, administered in left arm on 19Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history include COVID 19 from unknown onset and concomitant medications were not reported. On 20Feb2021, after the vaccination, the patient experienced fever, and on an unspecified date patient experienced pain, nausea, headaches, and weakness, Injection arm is sore, on 22Feb2021 patient experienced Three little pink blotchy areas. she had redness on her deltoid area, which she knows is normal from the things she read. She has three little pink blotchy areas that came up yesterday and hoping those go away. Her arm is still sore. Asked if that is going to impede her next dose in two weeks. She doesn't want to trigger another reaction. she started to feel sick, temperature went to 100.8, she was sweating. She had headache and nausea off and on. She was completely exhausted. She felt as though she did when she got her issues from the actual COVID virus. The patient lab data includes body temperature with reading of 100.8-degree Fahrenheit. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Lymph node pain, Pain, Pyrexia
Clinical narrative: Low-grade fever (100.4 F); Body aches; Headache; Injection site pain; bruising injection armpit; lymph node pain and swelling; This is a spontaneous report from a non-contactable consumer (patient herself). A 22-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, administered in left arm on 16Feb2021 10:00 (age at vaccination: 22 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249) via unknown route, in the left arm on 26Jan2021 10:00 as DOSE 1, SINGLE for covid-19 immunisation. On 16Feb2021 15:00, the patient experienced low-grade fever (100.4 f), body aches, headache, injection site pain, bruising injection armpit and lymph node pain and swelling. The patient was not diagnosed with covid prior vaccination nor was tested for covid since vaccination. The outcome of the events was recovered on an unknown date in 2021.   No follow up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Low-grade fever (100.4 F); Body aches; Headache; Injection site pain; bruising injection armpit; lymph node pain and swelling; This is a spontaneous report from a non-contactable consumer (patient herself). A 22-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, administered in left arm on 16Feb2021 10:00 (age at vaccination: 22 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3249) via unknown route, in the left arm on 26Jan2021 10:00 as DOSE 1, SINGLE for covid-19 immunisation. On 16Feb2021 15:00, the patient experienced low-grade fever (100.4 f), body aches, headache, injection site pain, bruising injection armpit and lymph node pain and swelling. The patient was not diagnosed with covid prior vaccination nor was tested for covid since vaccination. The outcome of the events was recovered on an unknown date in 2021.   No follow up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Cough, Dyspnoea, Malaise, Pain
Clinical narrative: Low grade fever; Aches and pains; Coughing; Trouble breathing; Wheezing; Not feeling well; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6203, Expiration date: unknown), dose 1 via an unspecified route of administration on 22Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated, received Pfizer vaccine first dose yesterday (further clarified) there was supposed to be some symptoms that comes along with that like low grade fever, aches and pains, coughing (Feb2021) but actually had some trouble breathing with wheezing and coughing (Feb2021) and wanted to know if that was normal. Patient again stated that not feeling really well (Feb2021). The patient underwent lab tests and procedures which included fever: low grade on an unspecified date in Feb2021. The clinical outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Wheezing
Clinical narrative: Low grade fever; Aches and pains; Coughing; Trouble breathing; Wheezing; Not feeling well; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6203, Expiration date: unknown), dose 1 via an unspecified route of administration on 22Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated, received Pfizer vaccine first dose yesterday (further clarified) there was supposed to be some symptoms that comes along with that like low grade fever, aches and pains, coughing (Feb2021) but actually had some trouble breathing with wheezing and coughing (Feb2021) and wanted to know if that was normal. Patient again stated that not feeling really well (Feb2021). The patient underwent lab tests and procedures which included fever: low grade on an unspecified date in Feb2021. The clinical outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Headache, Pain, Pain in extremity
Clinical narrative: Fever of 100.5; Body aches; Headache; Arm soreness; Dizziness; This is a spontaneous report from a contactable consumer (patient herself).  A 23-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Feb2021 13:30 (Batch/Lot Number: EL3247) (age at the vaccination 23-year-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient's historical vaccine included BNT162B2 (Batch/Lot number: EL3247) as dose 1, Arm Left single for covid-19 immunisation on 28Jan2021 01:30 PM (age at vaccination 23 years). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no Known allergies. On 18Feb2021 22:30, the patient had experienced fever of 100.5, body aches, headache, arm soreness and dizziness. The patient underwent lab tests and procedures which included body temperature: 100.5 on an unspecified date. The patient did not take treatment for the events. The outcome of events was recovered.   No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever of 100.5; Body aches; Headache; Arm soreness; Dizziness; This is a spontaneous report from a contactable consumer (patient herself).  A 23-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 18Feb2021 13:30 (Batch/Lot Number: EL3247) (age at the vaccination 23-year-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient's historical vaccine included BNT162B2 (Batch/Lot number: EL3247) as dose 1, Arm Left single for covid-19 immunisation on 28Jan2021 01:30 PM (age at vaccination 23 years). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no Known allergies. On 18Feb2021 22:30, the patient had experienced fever of 100.5, body aches, headache, arm soreness and dizziness. The patient underwent lab tests and procedures which included body temperature: 100.5 on an unspecified date. The patient did not take treatment for the events. The outcome of events was recovered.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Rash erythematous
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 52-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# E19263), at the age of 52, via an unspecified route of administration, left arm, on Feb 20, 2021, at 12:45 pm, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient has known allergies to tetracycline. Historical vaccine included the first dose of BNT162B2 for COVID-19 immunisation. The patient did not take any medications in the past two weeks. The patient did not receive any other vaccines within 4 weeks. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient hasn't tested for COVID-19. On Feb 22, 2021, at 04:00 am, after the second vaccination, patient had fever, chills and body aches that lasted approximately 12 hours. On Feb 22, 2021, evening of the second day after vaccination, she had a red rash  around her neck and on her chest and down her back. The outcome of red rash: unknown, while with other events: recovered (on an unspecified date Feb 2021). Follow-up (May 14, 2021): Follow-up attempts completed. No further information expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cold sweat, Fatigue, Feeling cold
Clinical narrative: Fever; really tired; Feeling cold; Cold sweat; Chills; This is a spontaneous report from a contactable consumer (Patient). A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EM9809), Solution for injection, intramuscular, administered in Arm Right on 08Feb2021 09:15 (at the age of 69-year-old) as single dose for covid-19 immunisation. Medical history was reported as none. There were no concomitant medications. Patient did not receive any other vaccine with four weeks of COVID vaccine. On an unspecified date in Feb2021, the patient experienced fever, really tired, feeling cold and chills. It was reported that, it had been 11 days since she received the vaccine. She had the vaccine on 08 Feb 2021 and Friday, 19 Feb 2021, or maybe the day before that, she began to feel really tired. But she put it down to it being weather related because her area has had a month of rain and she was tired of it. By Friday night, she was feeling very cold, but she didn't think about taking her temperature then. Saturday, she woke up having hard chills which went on all day long. She couldn't get warm. That afternoon, she took her temperature and it was almost 102 degrees. She took Tylenol and drank fluids and stayed in bed. Her seat was wrapped in a heating pad, trying to get warm. Sunday morning, she broke out in a cold sweat and the fever broke. Feeling much better yesterday, then last night, just before dark, the fever came back. She explained it was not quite as much of a fever, but the fever and chills came back. This morning, her fever had broken and she was feeling much better. With the number of days that passed to start with, she thought "do you have COVID?", But in reasoning, she didn't have any respiratory symptoms and other things to her knowledge would indicate COVID. After speaking with her daughter and talking to her about it, her daughter told her "you have a reaction". The patient underwent lab tests and procedures which included body temperature: 102 degrees in Feb2021. She took Tylenol and drank fluids as a therapeutic measure to treat adverse events. The adverse event was not resulted into emergency room or physician office visit. No test was performed. The outcome of events was unknown.   Follow-up attempts completed. No further information expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; really tired; Feeling cold; Cold sweat; Chills; This is a spontaneous report from a contactable consumer (Patient). A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EM9809), Solution for injection, intramuscular, administered in Arm Right on 08Feb2021 09:15 (at the age of 69-year-old) as single dose for covid-19 immunisation. Medical history was reported as none. There were no concomitant medications. Patient did not receive any other vaccine with four weeks of COVID vaccine. On an unspecified date in Feb2021, the patient experienced fever, really tired, feeling cold and chills. It was reported that, it had been 11 days since she received the vaccine. She had the vaccine on 08 Feb 2021 and Friday, 19 Feb 2021, or maybe the day before that, she began to feel really tired. But she put it down to it being weather related because her area has had a month of rain and she was tired of it. By Friday night, she was feeling very cold, but she didn't think about taking her temperature then. Saturday, she woke up having hard chills which went on all day long. She couldn't get warm. That afternoon, she took her temperature and it was almost 102 degrees. She took Tylenol and drank fluids and stayed in bed. Her seat was wrapped in a heating pad, trying to get warm. Sunday morning, she broke out in a cold sweat and the fever broke. Feeling much better yesterday, then last night, just before dark, the fever came back. She explained it was not quite as much of a fever, but the fever and chills came back. This morning, her fever had broken and she was feeling much better. With the number of days that passed to start with, she thought "do you have COVID?", But in reasoning, she didn't have any respiratory symptoms and other things to her knowledge would indicate COVID. After speaking with her daughter and talking to her about it, her daughter told her "you have a reaction". The patient underwent lab tests and procedures which included body temperature: 102 degrees in Feb2021. She took Tylenol and drank fluids as a therapeutic measure to treat adverse events. The adverse event was not resulted into emergency room or physician office visit. No test was performed. The outcome of events was unknown.   Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pyrexia
Clinical narrative: Had flu like symptoms with fever; Had flu like symptoms with fever; Fatigue; This is a spontaneous report from a non-contactable Other-HCP. This Adult male Other-HCP reported for himself. An adult male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN6200) via an intramuscular route of administration in Arm Left on 26Feb2021 11:30 as single dose for covid-19 immunisation. Medical history included urogram from an unknown date and unknown if ongoing IVP contrast dye. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Other medications in two weeks reported as none. The patient's concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EL9265) via an intramuscular route of administration in Arm Left on 06Feb2021 11:00AM as single dose for covid-19 immunisation. Since the vaccination, the patient had not been tested positive for COVID-19. The patient experienced had flu like symptoms with fever, fatigue on an unspecified date. The patient received treatment for the adverse events with antinausea meds. The clinical outcome of the events was recovering. Therapeutic measures were taken as a result of had flu like symptoms with fever, fatigue.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: diarrhea; vomiting; Had shot at 9am, by 3pm had a 99.9 fever; This is a spontaneous report from a contactable consumer (patient). A 51-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6205) via an unspecified route of administration on 27Feb2021 at 08:00 (at the age of 51-years-old) in left arm as a single dose for covid-19 immunization. Medical history included rosacea from an unknown date and unknown if ongoing. The patient did not receive any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with covid-19. The patient had no known allergies. Concomitant medications received in two weeks included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); mometasone furoate (NASONEX); bupropion hydrochloride (WELLBUTRIN) and doxycycline (DOXY [DOXYCYCLINE]) low dose time, all taken for an unspecified indication, start and stop date were not reported. The patient experienced fever of 99.9 on 27Feb2021 at 15:00. She woke up at 4 am with diarrhoea then vomiting on 28Feb2021. Till 3 pm she had vomited ever two hours since 4 am. The patient took Tylenol for fever and received no treatment for other events. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): negative on 20May2020. The outcome of all the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: chills; body aches; Headache; Fever; This is a spontaneous report from a contactable other HCP. This 23-year-old non-pregnant female other HCP (patient) reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via Intramuscularroute of administration on 25Feb2021 11:00 AM on left arm (at a23-year-old) as dose 2, single for COVID-19 immunization. The medical history of patient included anaemia (start date and ongoing status unknown). Concomitant medications included ethinylestradiol, norethisterone acetate (Junel), paroxetine at 10 mg and iron at 65 mg (taken for an unspecified indication, start and stop date were not reported). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, was not diagnosed with COVID-19 prior to vaccination, was not tested for covid-10 since the vaccination and had no allergies to medications, food, or other products. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via intramuscular route of administration on 4Feb2021 11:00 AM on left arm (at a23-year-old) as dose 1, number for COVID-19 immunization. On 25Feb2021 at 05:00 PM the patient experienced Fever, chills, pain and headache. The patient received treatment with Tylenol. On an unknown date in 2021 the patient recovered.  No follow-up attempts were needed; information about lot/batch number could not be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pain, Pyrexia
Clinical narrative: Low grade fever (max 100.6 degF) developed ~12hours after injection and lasted ~12hours.; Body aches and chills accompained the fever but faded when it did; Body aches and chills accompained the fever but faded when it did; Injection site soreness lasted - 48 hours; This is a spontaneous report from a contactable consumer reported for herself. A 23-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Arm Left on 25Feb2021 11:00 (at the age of 23-years-old) as a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) received within 2 weeks of vaccination included acetaminophen; ibuprofen. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Left on 04Feb2021 11:00 (at the age of 23-years-old) as a single dose for covid-19 immunization. The patient had allergy with nitrofurantoin. The patient was not pregnant at the time of vaccination. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Feb2021 02:00, the patient experienced low grade fever (max 100.6 degF) developed approximately 12hours after injection and lasted approximately 12hours. Body aches and chills accompanied the fever but faded when it did. Injection site soreness lasted approximately 48hours. The patient did not receive any treatment. Outcome of the event was not recovered, at the time of this report.  Follow-up attempts completed. No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Condition aggravated, Pyrexia, Somnolence
Clinical narrative: felt really sleepy and slept half the day; low grade temp / 96 degrees F. my Doctor told me that time I had my temp was 97.1, Ever since the vaccine my temperature has been running 97.5 degrees Fahrenheit  up to 98.7; low grade temp / 96 degrees F. my Doctor told me that time I had my temp was 97.1, Ever since the vaccine my temperature has been running 97.5 degrees Fahrenheit  up to 98.7; This is a spontaneous report from a contactable consumer or other non hcp. A 75-years-old female patient received second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: LWEN6198) via an unspecified route of administration, administered in Arm Left on 22Feb2021 10:50(age at vaccination 75Years) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included, ongoing Sjogren's syndrome She has had Sjogren's disease for 40 years. The patient's concomitant medications were not reported. patient previously received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number EL9265) via unspecified route of administration in Arm left on 02Feb2021(age at vaccination 75Years) as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced low grade temp / 96 degrees f. my doctor told me that time I had my temp was 97.1, ever since the vaccine my temperature has been running 97.5 degrees fahrenheit up to 98.7 on Feb2021, felt really sleepy and slept half the day on 28Feb2021, low grade temp / 96 degrees f. my doctor told me that time i had my temp was 97.1, ever since the vaccine my temperature has been running 97.5 degrees fahrenheit up to 98.7 on Feb2021. The patient underwent lab tests and procedures which included body temperature: 96 fahrenheit on unspecified date, body temperature: 97.1 fahrenheit on unspecified date, body temperature: 97.5-98.7 fahrenheit on unspecified date. Relevant tests were not reported. The outcome of the event somnolence was recovered, the outcome of the events pyrexia, condition aggravated was not recovered.  No follow-up attempts are possible. No further information is expected.